Previous Article | Next Article 
Molecular and Cellular Biology, March 2006, p. 1888-1897, Vol. 26, No. 5
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.5.1888-1897.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Inquiring into the Differential Action of Interferons (IFNs): an IFN-
2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-ß
Diego A. Jaitin,1
Laila C. Roisman,1
Eva Jaks,2
Martynas Gavutis,2
Jacob Piehler,2
Jose Van der Heyden,3
Gilles Uze,3 and
Gideon Schreiber1*
Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel,1
Institute of Biochemistry, Goethe University Frankfurt/Main, Frankfurt/Main, Germany,2
Laboratory of Antiviral Defenses, CNRS UMR 5124, Montpellier, France3
Received 20 September 2005/
Returned for modification 28 November 2005/
Accepted 13 December 2005
Alpha and beta interferons (IFN-
and IFN-ß) are multifunctional cytokines that exhibit differential activities through a common receptor composed of the subunits IFNAR1 and IFNAR2. Here we combined biophysical and functional studies to explore the mechanism that allows the alpha and beta IFNs to act differentially. For this purpose, we have engineered an IFN-
2 triple mutant termed the HEQ mutant that mimics the biological properties of IFN-ß. Compared to wild-type (wt) IFN-
2, the HEQ mutant confers a 30-fold higher binding affinity towards IFNAR1, comparable to that measured for IFN-ß, resulting in a much higher stability of the ternary complex as measured on model membranes. The HEQ mutant, like IFN-ß, promotes a differentially higher antiproliferative effect than antiviral activity. Both bring on a down-regulation of the IFNAR2 receptor upon induction, confirming an increased ternary complex stability of the plasma membrane. Oligonucleotide microarray experiments showed similar gene transcription profiles induced by the HEQ mutant and IFN-ß and higher levels of gene induction or repression than those for wt IFN-
2. Thus, we show that the differential activities of IFN-ß are directly related to the binding affinity for IFNAR1. Conservation of the residues mutated in the HEQ mutant within IFN-
subtypes suggests that IFN-
has evolved to bind IFNAR1 weakly, apparently to sustain differential levels of biological activities compared to those induced by IFN-ß.
* Corresponding author. Mailing address: Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel. Phone: 972 8 934 3249. Fax: 972 8 934 6095. E-mail: gideon.schreiber{at}weizmann.ac.il.
Molecular and Cellular Biology, March 2006, p. 1888-1897, Vol. 26, No. 5
0022-538X/06/$08.00+0 doi:10.1128/MCB.26.5.1888-1897.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Langer, J. A.
(2007). Interferon at 50: New Molecules, New Potential, New (and Old) Questions. Sci Signal
2007: pe53-pe53
[Abstract]
[Full Text]
-
Dunn, I. S., Haggerty, T. J., Kono, M., Durda, P. J., Butera, D., Macdonald, D. B., Benson, E. M., Rose, L. B., Kurnick, J. T.
(2007). Enhancement of Human Melanoma Antigen Expression by IFN-beta. J. Immunol.
179: 2134-2142
[Abstract]
[Full Text]
-
Brideau-Andersen, A. D., Huang, X., Sun, S.-C. C., Chen, T. T., Stark, D., Sas, I. J., Zadik, L., Dawes, G. N., Guptill, D. R., McCord, R., Govindarajan, S., Roy, A., Yang, S., Gao, J., Chen, Y. H., Skartved, N. J. O., Pedersen, A. K., Lin, D., Locher, C. P., Rebbapragada, I., Jensen, A. D., Bass, S. H., Nissen, T. L. S., Viswanathan, S., Foster, G. R., Symons, J. A., Patten, P. A.
(2007). Directed evolution of gene-shuffled IFN-{alpha} molecules with activity profiles tailored for treatment of chronic viral diseases. Proc. Natl. Acad. Sci. USA
104: 8269-8274
[Abstract]
[Full Text]
-
Reder, A.T.
(2007). Neutralizing antibodies in multiple sclerosis: a complex impact on interferon responses, magnetic resonance imaging findings and clinical outcomes. Mult Scler
13: 53-62
[Abstract]
-
Kalie, E., Jaitin, D. A., Abramovich, R., Schreiber, G.
(2007). An Interferon {alpha}2 Mutant Optimized by Phage Display for IFNAR1 Binding Confers Specifically Enhanced Antitumor Activities. J. Biol. Chem.
282: 11602-11611
[Abstract]
[Full Text]
-
Perreau, M., Mennechet, F., Serratrice, N., Glasgow, J. N., Curiel, D. T., Wodrich, H., Kremer, E. J.
(2007). Contrasting Effects of Human, Canine, and Hybrid Adenovirus Vectors on the Phenotypical and Functional Maturation of Human Dendritic Cells: Implications for Clinical Efficacy. J. Virol.
81: 3272-3284
[Abstract]
[Full Text]
-
Quadt-Akabayov, S. R., Chill, J. H., Levy, R., Kessler, N., Anglister, J.
(2006). Determination of the human type I interferon receptor binding site on human interferon-{alpha}2 by cross saturation and an NMR-based model of the complex. Protein Sci.
15: 2656-2668
[Abstract]
[Full Text]
-
Severa, M., Remoli, M. E., Giacomini, E., Ragimbeau, J., Lande, R., Uze, G., Pellegrini, S., Coccia, E. M.
(2006). Differential responsiveness to IFN-{alpha} and IFN-{beta} of human mature DC through modulation of IFNAR expression. J. Leukoc. Biol.
79: 1286-1294
[Abstract]
[Full Text]
-
Gavutis, M., Jaks, E., Lamken, P., Piehler, J.
(2006). Determination of the Two-Dimensional Interaction Rate Constants of a Cytokine Receptor Complex. Biophys. J
90: 3345-3355
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.